EDGAR Filing Documents for 0000950170-24-027505

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0000950170-24-027505

Filing Date

2024-03-06

Accepted

2024-03-06 20:07:37

Documents

Period of Report

2024-03-04

Document Format Files

Seq	Description	Document	Type	Size
1	4	ownership.html	4
1	4	ownership.xml	4	3277
	Complete submission text file	0000950170-24-027505.txt		4764

Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453

Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560

REPLIGEN CORP (Issuer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O REPLIGEN CORPORATION 41 SYON ST. BLDG. 1, SUITE 100 WALTHAM MA 02453

Business Address

Gebski Christine (Reporting) CIK: 0001849585 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14656 | Film No.: 24727829